経口固形製剤（OSD）受託製造の世界市場規模、シェア、動向分析レポート：製品タイプ別、メカニズム別、最終用途別、地域別、セグメント別予測（2024年～2030年）

経口固形製剤（OSD）受託製造市場の成長と動向：

世界の経口固形製剤受託製造の市場規模は、2030年までに547億米ドルに達し、2024年～2030年にCAGR5.97％で拡大すると予測されています。 新薬分子の複雑さの増加、 大手CMOおよびCDMOによる研究開発投資と新しい治療法に対する需要の高まりが、市場の成長を促進する重要な要因です。

経口固形物は、費用効果が高く、製造が簡単で、患者に優しいため、製薬分野で広く受け入れられている剤形です。 さらに、制御放出や徐放性形成などの薬物送達技術の進歩により、薬物投与頻度を下げながら、経口固形物がさらに高いレベルのバイオアベイラビリティを達成できるようになりました。 これにより、市場成長の可能性が促進されることが期待されています。

経口固形製剤の開発と大量製造における技術的進歩は、これらの製品の迅速な商業化を支える主な要因の一つです。現在、市場では多様な剤形が入手可能です。しかし、栄養補助食品業界と製薬業界は一貫してOSD剤形の開発に力を入れています。その理由は、取り扱いが容易で、摂取が便利で、患者の服薬アドヒアランスが良好なためです。OSD製剤の技術や材料の進歩が見込まれ、これらの製剤の需要を押し上げると予測されています。

さらに、CMOやCDMOによる研究開発投資は、製造プロセス、製剤開発、分析技術における技術革新の強化に寄与しています。これは、経口固形製剤の製造において、より効率的で高度な製造技術の採用につながる可能性があります。また、研究開発への投資は製造能力の拡大と拡張性の向上につながります。これによりCMOやCDMOは、製薬会社からの需要の増加に対応するため、より大量の経口固形製剤を提供できるようになります。

さらに、この業界では2023年に、提携、パートナーシップ、M&A、サービス拡大など、多くの戦略的な動きが見られました。

• 2023年7月、アエノバ・グループとGalvitaは、経口剤の製剤化、生産、開発を改善するための戦略的パートナーシップを締結しました。
• 2023年4月、Aenova は約2,196万米ドル (2,000万ユーロ) を投資してティットモニングの大量固形剤サイトを拡張し、生産能力が増加しました。
• 2023年1月、CatalentとEthicannは協力して、口腔崩壊錠 (ODT) 技術として知られる Catalentの技術を使用してEthicannの臨床医薬品パイプラインを開発しました。

経口固形製剤（OSD）受託製造市場レポートハイライト

• 2023年の売上高シェアは錠剤セグメントが32.7%で市場を独占しました。錠剤は、費用対効果、コンパクト性、製造の容易さ、自己投与の利便性から、最も一般的で好まれるOSD形態です。二層錠に対する需要の増加と、製剤化および放出制御錠剤製造の拡大のための企業による投資が、市場の成長を促進すると予測されます。
• 2023年には放出制御セグメントが52.2%という最大のシェアを占めました。この成長は、ドーム錠、二剤併用錠剤、腸パッチ、ポリマーナノシステム、エキソソームなどの正確な薬物送達のための生物由来の送達方法を含む経口放出制御送達システムの進歩によるものです。 したがって、制御放出剤形に対する高い需要により、近い将来、セグメントの収益成長が促進されると予想されます。
• 最終用途別では、大規模企業セグメントは2023年に54.8%の最大シェアを占めました。固形製剤製造市場は、協業、柔軟性、高い適応性によってますます定義されるようになっています。医薬品を最初から設計し、大手CMOに委託することを意図する製薬開発企業が増えており、それによって市場の成長が加速しています。さらに、経口固形製剤を専門とするCMOは、大手製薬会社にメリットを提供できるため、採用が増加しています。
• アジア太平洋は2023年の世界市場をリードし、予測期間中のCAGRは6.3%と最も速いと予測されています。中国とインドは経口固形製剤受託製造大国であり、価格も大幅に安くなっています。さらに、シンガポール、インド、韓国などのアジア諸国は、製造能力の拡大により、医薬品業界の主要プレーヤーと見なされています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経口固形製剤（OSD）受託製造市場：変数、動向、範囲

• 市場系統の見通し
• 市場力学
• 経口固形製剤（OSD）受託製造市場：分析ツール
• COVID-19の影響分析
• 経口固形製剤（OSD）の包装タイプに関する分析：ブリスターvs.ボトル（容量%シェア、2022年）

第4章 経口固形製剤（OSD）受託製造市場：セグメント分析、製品タイプ別（2018年～2030年）

• 経口固形製剤（OSD）受託製造市場：製品タイプ別、重要ポイント
• 経口固形製剤（OSD）受託製造市場：製品タイプの変動分析
• 製品タイプ別

第5章 経口固形製剤（OSD）受託製造市場：メカニズム分析

• 経口固形製剤（OSD）受託製造市場：メカニズム別、重要ポイント
• 経口固形製剤（OSD）受託製造市場：メカニズムの変動分析
• メカニズム別

第6章 経口固形製剤（OSD）受託製造市場：最終用途分析

• 経口固形製剤（OSD）受託製造市場：最終用途別、重要ポイント
• 経口固形製剤（OSD）受託製造市場：最終用途の変動分析
• 最終用途別

第7章 経口固形製剤（OSD）受託製造市場：地域分析

• 経口固形製剤受託製造（OSD）：市場シェア分析（2023年・2030年）
• 地域別
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 企業情勢
  • Richter-Helm BioLogics
  • Lonza
  • Catalent, Inc
  • Aenova Group
  • Boehringer Ingelheim International GmbH
  • Jubilant Pharmova Limited
  • Patheon Pharma Services
  • Recipharm AB.
  • Corden Pharma International
  • Siegfried Holding AG
  • Piramal Pharma Solutions
  • AbbVie Contract Manufacturing
  • Next Pharma AB
• 企業の分類
• 製品/サービスのヒートマップ分析
• 戦略への取り組み
  • 買収
  • コラボレーション
  • 事業拡大
  • サービス開始
  • パートナーシップ
  • その他

第9章 重要ポイント

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 4 North America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 5 North America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 6 U.S. Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 7 U.S. Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 8 U.S. Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 9 Canada Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 10 Canada Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 11 Canada Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 12 Europe Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 14 Europe Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 16 UK Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 17 UK Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 18 UK Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Germany Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 20 Germany Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 21 Germany Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 22 France Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 23 France Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 24 France Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Italy Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 26 Italy Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 27 Italy Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 28 Spain Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 29 Spain Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 30 Spain Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 31 Denmark Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 32 Denmark Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 33 Denmark Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 34 Sweden Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 35 Sweden Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 36 Sweden Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 37 Norway Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 38 Norway Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 39 Norway Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 44 China Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 45 China Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 46 China Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 47 India Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 48 India Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 49 India Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 50 Japan Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
• Table 51 Japan Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 52 Japan Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Australia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 54 Australia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 55 Australia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 56 South Korea Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 57 South Korea Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 58 South Korea Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 59 Thailand Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 60 Thailand Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 61 Thailand Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 62 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 64 Latin America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Brazil Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million) 2018 - 2030
• Table 67 Brazil Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 68 Brazil Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Mexico Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 70 Mexico Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 71 Mexico Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 72 Argentina Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 73 Argentina Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 74 Argentina Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 77 MEA Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 78 MEA Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 79 South Africa Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 80 South Africa Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 81 South Africa Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 85 UAE Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 86 UAE Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 87 UAE Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)
• Table 88 Kuwait Oral Solid Dosage Contract Manufacturing market, by product type, 2018 - 2030 (USD Million)
• Table 89 Kuwait Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018 - 2030 (USD Million)
• Table 90 Kuwait Oral Solid Dosage Contract Manufacturing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Oral solid dosage contract manufacturing market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Commodity flow analysis
• Fig. 8 Value-Chain-Based Sizing & Forecasting
• Fig. 9 QFD model sizing & forecasting
• Fig. 10 Market formulation & validation
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Parent market outlook, 2023 (USD Million)
• Fig. 16 Ancillary market outlook, 2023 (USD Million)
• Fig. 17 Oral solid dosage contract manufacturing market dynamics
• Fig. 18 Biosimilar approval in the U.S. and EU per year (2016 - 2021)
• Fig. 19 Porter's five forces analysis
• Fig. 20 PESTEL analysis
• Fig. 21 Oral solid dosage packaging types in the U.S., 2023 (volume percentage share %)
• Fig. 22 Oral solid dosage blister packaging types in the U.S., 2023 (volume percentage share %)
• Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
• Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
• Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
• Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
• Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
• Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
• Fig. 37 Large-size companies market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 38 Medium- & small- sized companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 40 Regional market: Key takeaways
• Fig. 41 Regional outlook, 2023 & 2030
• Fig. 42 Regional outlook, 2023 & 2030
• Fig. 43 North America market, 2018 - 2030 (USD Million)
• Fig. 44 Key country dynamics
• Fig. 45 U.S. Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 Canada Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Europe Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 UK Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Germany Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 France Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Italy Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Spain Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Denmark Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Sweden Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Norway Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 China Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
• Fig. 70 India Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Clinical trial authorization process in Japan
• Fig. 73 Clinical Research of Medical Products in Japan
• Fig. 74 Japan Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 78 Australia Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Clinical trial approval process in South Korea
• Fig. 81 South Korea Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Thailand Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Clinical trial authorization process UAE
• Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 99 Key country dynamics
• Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 101 Key company categorization
• Fig. 102 Product/service heat map analysis

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is expected to reach USD 54.7 billion by 2030 and expand at a CAGR of 5.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

• In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
• In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
• In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

• The tablets segment dominated the market with a revenue share of 32.7% in 2023. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth
• The controlled release segment accounted for the largest share of 52.2% in 2023. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future
• Based on end-use, the large size companies segment accounted for the largest share of 54.8% in 2023. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption
• Asia Pacific led the global market in 2023 and is projected to witness the fastest CAGR of 6.3% during the forecast years. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
  • 1.5.1 Region Wise Market Calculation
  • 1.5.2 Region Wise Market: Base Estimates
  • 1.5.3 Global Market: Cagr Calculation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.6.2 Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3 Qfd Model Sizing & Forecasting (Model 3)
• 1.7 Market Formulation & Validation
• 1.8 Market Definitions/Scope
• 1.9 List Of Secondary Sources
• 1.10 List Of Primary Sources
• 1.11 List Of Abbreviations
• 1.12 Objectives
  • 1.12.1 Objective - 1
  • 1.12.2 Objective - 2
  • 1.12.3 Objective - 3
  • 1.12.4 Objective - 4

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Oral Solid Dosage Contract Manufacturing Market: Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Technological Advancements In Oral Solid Dosage (Osd) Forms
    • 3.2.1.2 Expansion Of Manufacturing Capacity By Cmos & Cdmos For Osd
    • 3.2.1.3 Increasing Demand For Novel Therapies
    • 3.2.1.4 Increasing Demand For One-Stop-Shop Cdmos
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Strict Approval Criteria By Regulatory Authorities
    • 3.2.2.2 Lack Of Experienced Technical Staff, Physical Capability, And Equipment Capacity
    • 3.2.2.3 Increasing Need For Biosimilars And Their Prominence In Addressing Cancer & Other Medical Conditions
• 3.3 Oral Solid Dosage Contract Manufacturing Market: Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 Pestel Analysis
• 3.4 Covid-19 Impact Analysis
• 3.5 Analysis Pertaining To Oral Solid Dosage Packaging Types, By Blisters Vs. Bottles (Volume % Share, 2022)
  • 3.5.1 Blister Packaging
  • 3.5.2 Bottle Packaging
  • 3.5.3 Types Of Blister Packaging
  • 3.5.4 Blister Packaging

Chapter 4 Oral Solid Dosage Contract Manufacturing Market: Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

• 4.1 Oral Solid Dosage Contract Manufacturing Market By Product Type: Key Takeaways
• 4.2 Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
• 4.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Product Type (USD Million)
  • 4.3.1 Tablets
    • 4.3.1.1 Tablets Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 4.3.2 Capsules
    • 4.3.2.1 Capsules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 4.3.3 Powders
    • 4.3.3.1 Powders Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 4.3.4 Granules
    • 4.3.4.1 Granules Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 4.3.5 Others
    • 4.3.5.1 Others Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 5 Oral Solid Dosage Contract Manufacturing Market: Mechanism Analysis

• 5.1 Oral Solid Dosage Contract Manufacturing Market By Mechanism Segment: Key Takeaways
• 5.2 Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
• 5.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Mechanism (USD Million)
  • 5.3.1 Immediate Release (IR)
    • 5.3.1.1 Immediate Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 5.3.2 Delayed Release
    • 5.3.2.1 Delayed Release Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 5.3.3 Controlled Release (CR)
    • 5.3.3.1 Controlled Release Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 6 Oral Solid Dosage Contract Manufacturing Market: End-Use Analysis

• 6.1 Oral Solid Dosage Contract Manufacturing Market, By End-Use Segment: Key Takeaways
• 6.2 Oral Solid Dosage Contract Manufacturing Market: End-Use Movement Analysis
• 6.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By End-Use (USD Million)
  • 6.3.1 Large-Size Companies
    • 6.3.1.1 Large-Size Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 6.3.2 Medium- & Small-Size Companies
    • 6.3.2.1 Medium- & Small- Sized Companies Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 6.3.3 Others
    • 6.3.3.1 Others Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 7 Oral Solid Dosage Contract Manufacturing Market: Regional Analysis

• 7.1 Oral Solid Dosage Contract Manufacturing: Market Share Analysis, 2023 & 2030
• 7.2 Oral Solid Dosage Contract Manufacturing: Market Estimates And Forecasts, By Region (USD Million)
• 7.3 North America
  • 7.3.1 North America Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 7.3.2 U.S.
    • 7.3.2.1 Key Country Dynamics
    • 7.3.2.2 Competitive Scenario
    • 7.3.2.3 Regulatory Scenario
    • 7.3.2.4 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3 Canada
    • 7.3.3.1 Key Country Dynamics
    • 7.3.3.2 Competitive Scenario
    • 7.3.3.3 Regulatory Scenario
    • 7.3.3.4 Canada Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.4 Europe
  • 7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million)
  • 7.4.2 Uk
    • 7.4.2.1 Key Country Dynamics
    • 7.4.2.2 Competitive Scenario
    • 7.4.2.3 Regulatory Scenario
    • 7.4.2.4 Uk Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3 Germany
    • 7.4.3.1 Key Country Dynamics
    • 7.4.3.2 Competitive Scenario
    • 7.4.3.3 Regulatory Scenario
    • 7.4.3.4 Germany Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4 France
    • 7.4.4.1 Key Country Dynamics
    • 7.4.4.2 Competitive Scenario
    • 7.4.4.3 Regulatory Scenario
    • 7.4.4.4 France Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5 Italy
    • 7.4.5.1 Key Country Dynamics
    • 7.4.5.2 Competitive Scenario
    • 7.4.5.3 Regulatory Scenario
    • 7.4.5.4 Italy Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6 Spain
    • 7.4.6.1 Key Country Dynamics
    • 7.4.6.2 Competitive Scenario
    • 7.4.6.3 Regulatory Scenario
    • 7.4.6.4 Spain Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7 Denmark
    • 7.4.7.1 Key Country Dynamics
    • 7.4.7.2 Competitive Scenario
    • 7.4.7.3 Regulatory Scenario
    • 7.4.7.4 Denmark Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.4.8 Sweden
    • 7.4.8.1 Key Country Dynamics
    • 7.4.8.2 Competitive Scenario
    • 7.4.8.3 Regulatory Scenario
    • 7.4.8.4 Sweden Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.4.9 Norway
    • 7.4.9.1 Key Country Dynamics
    • 7.4.9.2 Competitive Scenario
    • 7.4.9.3 Regulatory Scenario
    • 7.4.9.4 Norway Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
• 7.5 Asia Pacific
  • 7.5.1 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, 2018 - 2030 (USD Million
  • 7.5.2 China
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Scenario
    • 7.5.2.4 China Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3 India
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Scenario
    • 7.5.3.4 India Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4 Japan
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Scenario
    • 7.5.4.4 Japan Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5 Australia
    • 7.5.5.1 Key Country Dynamics
    • 7.5.5.2 Competitive Scenario
    • 7.5.5.3 Regulatory Scenario
    • 7.5.5.4 Australia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6 South Korea
    • 7.5.6.1 Key Country Dynamics
    • 7.5.6.2 Competitive Scenario
    • 7.5.6.3 Regulatory Scenario
    • 7.5.6.4 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7 Thailand
    • 7.5.7.1 Key Country Dynamics
    • 7.5.7.2 Competitive Scenario
    • 7.5.7.3 Regulatory Scenario
    • 7.5.7.4 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6 Latin America
  • 7.6.1 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2 Brazil
    • 7.6.2.1 Key Country Dynamics
    • 7.6.2.2 Competitive Scenario
    • 7.6.2.3 Regulatory Scenario
    • 7.6.2.4 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3 Mexico
    • 7.6.3.1 Key Country Dynamics
    • 7.6.3.2 Competitive Scenario
    • 7.6.3.3 Regulatory Scenario
    • 7.6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4 Argentina
    • 7.6.4.1 Key Country Dynamics
    • 7.6.4.2 Competitive Scenario
    • 7.6.4.3 Regulatory Scenario
    • 7.6.4.4 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
• 7.7 MEA
  • 7.7.1 MEA Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.7.2 South Africa
    • 7.7.2.1 Key Country Dynamics
    • 7.7.2.2 Competitive Scenario
    • 7.7.2.3 Regulatory Scenario
    • 7.7.2.4 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.7.3 Saudi Arabia
    • 7.7.3.1 Key Country Dynamics
    • 7.7.3.2 Competitive Scenario
    • 7.7.3.3 Regulatory Scenario
    • 7.7.3.4 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030, (USD Million)
  • 7.7.4 UAE
    • 7.7.4.1 Key Country Dynamics
    • 7.7.4.2 Competitive Scenario
    • 7.7.4.3 Regulatory Scenario
    • 7.7.4.4 UAE Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5 Kuwait
    • 7.7.5.1 Key Country Dynamics
    • 7.7.5.2 Competitive Scenario
    • 7.7.5.3 Regulatory Scenario
    • 7.7.5.4 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

• 8.1. Company Landscape
  • 8.1.1. Richter-Helm BioLogics
    • 8.1.1.1. Company overview
    • 8.1.1.2. Financial performance
    • 8.1.1.3. Product benchmarking
    • 8.1.1.4. Strategic initiatives
  • 8.1.2. Lonza
    • 8.1.2.1. Company overview
    • 8.1.2.2. Financial performance
    • 8.1.2.3. Product benchmarking
    • 8.1.2.4. Strategic initiatives
  • 8.1.3. Catalent, Inc
    • 8.1.3.1. Company overview
    • 8.1.3.2. Financial performance
    • 8.1.3.3. Product benchmarking
    • 8.1.3.4. Strategic initiatives
  • 8.1.4. Lonza
    • 8.1.4.1. Company overview
    • 8.1.4.2. Financial performance
    • 8.1.4.3. Product benchmarking
    • 8.1.4.4. Strategic initiatives
  • 8.1.5. Aenova Group
    • 8.1.5.1. Company overview
    • 8.1.5.2. Financial performance
    • 8.1.5.3. Product benchmarking
    • 8.1.5.4. Strategic initiatives
  • 8.1.6. Boehringer Ingelheim International GmbH
    • 8.1.6.1. Company overview
    • 8.1.6.2. Financial performance
    • 8.1.6.3. Product benchmarking
    • 8.1.6.4. Strategic initiatives
  • 8.1.7. Jubilant Pharmova Limited
    • 8.1.7.1. Company overview
    • 8.1.7.2. Financial performance
    • 8.1.7.3. Product benchmarking
    • 8.1.7.4. Strategic initiatives
  • 8.1.8. Patheon Pharma Services
    • 8.1.8.1. Company overview
    • 8.1.8.2. Financial performance
    • 8.1.8.3. Product benchmarking
    • 8.1.8.4. Strategic initiatives
  • 8.1.9. Recipharm AB.
    • 8.1.9.1. Company overview
    • 8.1.9.2. Financial performance
    • 8.1.9.3. Product benchmarking
    • 8.1.9.4. Strategic initiatives
  • 8.1.10. Corden Pharma International
    • 8.1.10.1. Company overview
    • 8.1.10.2. Financial performance
    • 8.1.10.3. Product benchmarking
    • 8.1.10.4. Strategic initiatives
  • 8.1.11. Siegfried Holding AG
    • 8.1.11.1. Company overview
    • 8.1.11.2. Financial performance
    • 8.1.11.3. Product benchmarking
    • 8.1.11.4. Strategic initiatives
  • 8.1.12. Piramal Pharma Solutions
    • 8.1.12.1. Company overview
    • 8.1.12.2. Financial performance
    • 8.1.12.3. Product benchmarking
    • 8.1.12.4. Strategic initiatives
  • 8.1.13. AbbVie Contract Manufacturing
    • 8.1.13.1. Company overview
    • 8.1.13.2. Financial performance
    • 8.1.13.3. Product benchmarking
    • 8.1.13.4. Strategic initiatives
  • 8.1.14. Next Pharma AB
    • 8.1.14.1. Company overview
    • 8.1.14.2. Financial performance
    • 8.1.14.3. Product benchmarking
    • 8.1.14.4. Strategic initiatives
• 8.2 Company Categorization
• 8.3 Product/Service Heat Map Analysis
• 8.4 Strategy Initiatives
  • 8.4.1 Acquisition
  • 8.4.2 Collaboration
  • 8.4.3 Expansion
  • 8.4.4 Service Launch
  • 8.4.5 Partnership
  • 8.4.6 Others

Chapter 9 Key Takeaways